- Home
- UBXG vs NRXP Comparison
UBXG vs NRXP Comparison
Compare UBXG & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBXG
- NRXP
- Stock Information
- Founded
- UBXG 2018
- NRXP 2015
- Country
- UBXG China
- NRXP United States
- Employees
- UBXG N/A
- NRXP N/A
- Industry
- UBXG
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- UBXG
- NRXP Health Care
- Exchange
- UBXG Nasdaq
- NRXP Nasdaq
- Market Cap
- UBXG 60.1M
- NRXP 58.5M
- IPO Year
- UBXG 2024
- NRXP N/A
- Fundamental
- Price
- UBXG $2.00
- NRXP $3.01
- Analyst Decision
- UBXG
- NRXP Strong Buy
- Analyst Count
- UBXG 0
- NRXP 5
- Target Price
- UBXG N/A
- NRXP $31.40
- AVG Volume (30 Days)
- UBXG 597.6K
- NRXP 498.6K
- Earning Date
- UBXG 01-01-0001
- NRXP 11-13-2025
- Dividend Yield
- UBXG N/A
- NRXP N/A
- EPS Growth
- UBXG N/A
- NRXP N/A
- EPS
- UBXG N/A
- NRXP N/A
- Revenue
- UBXG $39,603,353.00
- NRXP N/A
- Revenue This Year
- UBXG N/A
- NRXP N/A
- Revenue Next Year
- UBXG N/A
- NRXP $231.16
- P/E Ratio
- UBXG N/A
- NRXP N/A
- Revenue Growth
- UBXG N/A
- NRXP N/A
- 52 Week Low
- UBXG $1.84
- NRXP $1.10
- 52 Week High
- UBXG $13.60
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- UBXG 33.04
- NRXP 57.76
- Support Level
- UBXG $1.84
- NRXP $2.91
- Resistance Level
- UBXG $2.96
- NRXP $3.18
- Average True Range (ATR)
- UBXG 0.30
- NRXP 0.24
- MACD
- UBXG -0.09
- NRXP 0.04
- Stochastic Oscillator
- UBXG 12.69
- NRXP 82.72
About UBXG U-BX Technology Ltd. Ordinary Shares
U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.